Pallini, Greece

Rumit Rajivbhai Shah

This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Ntc S.r.l.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rumit Rajivbhai Shah. Retrieved from https://idiyas.com/inventor/rumit-rajivbhai-shah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rumit Rajivbhai Shah: Innovator in Pharmaceutical Composition

Introduction

Rumit Rajivbhai Shah is an accomplished inventor based in Pallini Attikis, Greece. He currently works at Pharmathen S.A., where he focuses on developing innovative pharmaceutical solutions. Despite having no granted patents to his name, Shah is actively involved in the field of pharmaceutical compositions.

Latest Patent Applications

Shah has submitted several notable patent applications, including:

1. **Preservative Free Pharmaceutical Composition for Ophthalmic Administration Containing Cyclosporine** - This invention relates to a stable preservative-free Cyclosporine emulsion in the form of eye drops. It includes a process for manufacturing the product, which is packed in a container that ensures stability for the treatment of keratoconjunctivitis sicca.

2. **Sustained Release Composition Comprising Tapentadol and Method of Preparation Thereof** - This application pertains to a sustained release and abuse-proof composition comprising Tapentadol or a pharmaceutically acceptable salt for oral administration. It is designed for the treatment of severe chronic pain in adults.

Conclusion

Rumit Rajivbhai Shah is a dedicated inventor making strides in the pharmaceutical industry through his innovative applications. His work aims to enhance treatment options for patients, showcasing his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…